MRF-Logo2019-Horizontal-RGB
On Yeroy (ipilimumab) or questions? Free Support & Educaton Program
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

On Yeroy (ipilimumab) or questions? Free Support & Educaton Program

› Forums › General Melanoma Community › On Yeroy (ipilimumab) or questions? Free Support & Educaton Program

  • This topic is empty.
  • Post
    • February 23, 2014 at 7:49 am
    NursePhyllis
    Participant

      Bristol Myers has started a new patient education and support program for anyone on yervoy and its free. you can enroll from home at https://yervoyyesprogram.com The program assigns you a nurse that you can call 24/7 with any questions about the drug or side effects.   As a former melanoma nurse I looked through it and it looks like a good program for patients who have questions and need to talk to someone

    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics